Atlas Trials

A Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of an Intravenous Solution of JNJ-39588146 or Placebo in Patients With Heart Failure

Clinical trial NCT01120210 · COMPLETED

Trial details

NCT number
NCT01120210
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Heart Failure
Start date
2010-06-01
Primary completion
2011-09-01
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.